Ionis Pharmaceuticals Inc (STU:ISI)
€ 34.62 0.13 (0.38%) Market Cap: 5.44 Bil Enterprise Value: 4.45 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 59/100

Q1 2024 Ionis Pharmaceuticals Inc Earnings Call Transcript

May 07, 2024 / 03:30PM GMT
Release Date Price: €38.99 (-0.48%)
Operator

Good morning, and welcome to Ionis' First Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin.

D. Wade Walke
Ionis Pharmaceuticals, Inc. - SVP of IR

Thank you, Keith. Before we begin, I encourage everyone to go to the Investors section of the Ionis website to view the press release and the related financial tables we will be discussing today, including the reconciliation of GAAP to non-GAAP financials. We believe non-GAAP financial results better represent the economics of our business and how we manage our business. We've also posted slides on our website that accompany today's call. With me this morning are Brett Monia, Chief Executive Officer; Kyle Jenne, Chief Global Product Strategy Officer; and Beth Hougen, Chief Financial Officer. Richard Geary, our Chief Development Officer; Eric Swayze, Executive Vice President of Research; Eugene Schneider, Chief Clinical Development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot